Bethany Buchanan
Family · Anchorage, AKNPI 1477517969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 25.1% of the total. Reporting peaked in 2022 at $947 and has fallen 64.2% since, to $339 in 2025. Among family clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $29.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$974
- Novo Nordisk$847
- AstraZeneca$436
- Antares Pharma, Inc.$431
- Lilly USA, LLC$249
- Biohaven Pharmaceutical Holding Company Ltd.$200
- plus $736 from 15 others
What the payments were for
- Food & beverage$3,873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $974 |
| Novo Nordisk | 30 | $847 |
| AstraZeneca | 7 | $436 |
| Antares Pharma, Inc. | 6 | $431 |
| Lilly USA, LLC | 10 | $249 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $200 |
| Astellas Pharma US Inc | 5 | $114 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $104 |
| Axsome Therapeutics, Inc. | 2 | $92 |
| Pfizer | 3 | $60 |
| Endo Pharmaceuticals Inc. | 3 | $59 |
| Biohaven Pharmaceuticals, Inc. | 3 | $56 |
| QOL Medical, LLC | 2 | $46 |
| Merck | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Gilead | 1 | $26 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Halozyme Inc | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,873 in reported general payments places this provider in the 90th percentile of 315 family providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 40 | $4,370 |
| Candesartan Cilexetil | 15 | $2,204 |
| SynthroidLevothyroxine Sodium | 17 | $1,727 |
| ProgesteroneProgesterone, Micronized | 40 | $1,568 |
| Armour ThyroidThyroid,pork | 15 | $1,418 |
| Levothyroxine Sodium | 102 | $1,186 |
| Np ThyroidThyroid,pork | 13 | $1,143 |
| Losartan Potassium | 27 | $504 |
| Metoprolol Succinate | 12 | $367 |
| Rosuvastatin Calcium | 25 | $327 |
| Bupropion Hcl SrBupropion Hcl | 19 | $253 |
| Metformin Hcl ErMetformin Hcl | 19 | $215 |
| Lamotrigine | 11 | $138 |
| Amlodipine Besylate | 12 | $132 |
| Minoxidil | 16 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid, Armour Thyroid | $974 | $3,14632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 315 family providers in Alaska.
Other family in Anchorage
- Erica HeagyAnchorage$249K
- Trisha KernodleAnchorage$60K
- Marisha DietersAnchorage$6K
- Christine HooverAnchorage$6K
- Leigh KeeferAnchorage$5K
- Sara GeraciAnchorage$4K
- Christine SaganAnchorage$4K
- Natasha SherrillAnchorage$4K
- Katherine HardyAnchorage$3K
- Andrea BirchAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.